English 
遺伝子組み換えによる医療革命GMOインターネットグループでGMOイプシロン株式会社の連結子会社であるGMOリザーブプラス株式会社が提供する医療予約管理システム「GMOリザーブプラス」は、2025年3月31日（月）より、PHCホールディングス株式会社の子会社である株式会社WeMEXが提供するクリニックシステム「メディコム」シリーズとのAPI連携を開始いたしました。
This means that clinics that are already using WeMEX’s “Medicom” series of clinical systems can add “Medical Revolution byGMO” to their systems, enabling them to create smoother medical treatment flows and improve operational efficiency.
For over 50 years since launching Japan’s first medical-receipt computer in 1972, WeMEX has provided a variety of “healthcare solutions” to streamline the work of people involved in medical care and increase the value of each individual. Products that meet the needs of the field have a high market share.
Meanwhile, since joining the GMO Internet Group in 2018, GMO-RP has aimed to revolutionize clinic management by providing a SaaS-based reservation management system as its core business, and has collaborated with services that promote medical digital transformation, such as online medical interviews, online medical treatment, and cashless payments. As a result of its constant challenge and continued growth, the number of active customers for its flagship products, the medical-specific reservation management system “Medical Revolution byGMO” and the dental reservation management system “Dentry byGMO,” has exceeded 2,000 facilities, and the company has achieved a high market share for SaaS products in the medical industry.
こちらもお読みください： アガサコーポレーション、ARCHIMED社から出資を獲得
“Medicom Cloud Connect API,” a cloud integration system from WeMEX, has been used by “メディコム Cloud Connect API” to enable API integration with electronic medical record systems, enabling seamless integration of reservation information, patient information, medical interview content, consultation status, accounting information, and more.
GMO-RPは、今後も圧倒的な開発力を背景に、高度な予約最適化エンジンを活用したサービスを提供することで、病院・診療所・歯科医院・動物病院の医療経営改革を加速させてまいります。
ソース PRタイムズ
日本語